Stockholders' Equity Attributable to Parent of 10x Genomics, Inc. from 31 Dec 2016 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
- Summary
-
10x Genomics, Inc. quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
- 10x Genomics, Inc. Stockholders' Equity Attributable to Parent for the quarter ending 31 Dec 2025 was $796,326,000, a 12% increase year-over-year.
- Source SEC data
- View on sec.gov
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)
10x Genomics, Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $796,326,000 | +$86,192,000 | +12% | 31 Dec 2025 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q3 2025 | $785,120,000 | +$62,316,000 | +8.6% | 30 Sep 2025 | 10-Q | 07 Nov 2025 | 2025 | Q3 |
| Q2 2025 | $773,279,000 | +$49,221,000 | +6.8% | 30 Jun 2025 | 10-Q | 07 Nov 2025 | 2025 | Q3 |
| Q1 2025 | $706,895,000 | -$11,939,000 | -1.7% | 31 Mar 2025 | 10-Q | 07 Nov 2025 | 2025 | Q3 |
| Q4 2024 | $710,134,000 | -$30,909,000 | -4.2% | 31 Dec 2024 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q3 2024 | $722,804,000 | -$22,412,000 | -3% | 30 Sep 2024 | 10-Q | 07 Nov 2025 | 2025 | Q3 |
| Q2 2024 | $724,058,000 | -$69,243,000 | -8.7% | 30 Jun 2024 | 10-Q | 07 Nov 2025 | 2025 | Q3 |
| Q1 2024 | $718,834,000 | -$83,551,000 | -10% | 31 Mar 2024 | 10-Q | 07 Nov 2025 | 2025 | Q3 |
| Q4 2023 | $741,043,000 | -$64,700,000 | -8% | 31 Dec 2023 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q3 2023 | $745,216,000 | -$30,576,000 | -3.9% | 30 Sep 2023 | 10-Q | 29 Oct 2024 | 2024 | Q3 |
| Q2 2023 | $793,301,000 | +$9,785,000 | +1.2% | 30 Jun 2023 | 10-Q | 29 Oct 2024 | 2024 | Q3 |
| Q1 2023 | $802,385,000 | -$4,300,000 | -0.53% | 31 Mar 2023 | 10-Q | 29 Oct 2024 | 2024 | Q3 |
| Q4 2022 | $805,743,000 | -$11,825,000 | -1.4% | 31 Dec 2022 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q3 2022 | $775,792,000 | -$24,429,000 | -3.1% | 30 Sep 2022 | 10-Q | 03 Nov 2023 | 2023 | Q3 |
| Q2 2022 | $783,516,000 | -$1,070,000 | -0.14% | 30 Jun 2022 | 10-Q | 03 Nov 2023 | 2023 | Q3 |
| Q1 2022 | $806,685,000 | +$54,225,000 | +7.2% | 31 Mar 2022 | 10-Q | 03 Nov 2023 | 2023 | Q3 |
| Q4 2021 | $817,568,000 | +$78,496,000 | +11% | 31 Dec 2021 | 10-K | 13 Feb 2025 | 2024 | FY |
| Q3 2021 | $800,221,000 | -$24,859,000 | -3% | 30 Sep 2021 | 10-Q | 03 Nov 2022 | 2022 | Q3 |
| Q2 2021 | $784,586,000 | +$393,317,000 | +101% | 30 Jun 2021 | 10-Q | 03 Nov 2022 | 2022 | Q3 |
| Q1 2021 | $752,460,000 | +$343,392,000 | +84% | 31 Mar 2021 | 10-Q | 03 Nov 2022 | 2022 | Q3 |
| Q4 2020 | $739,072,000 | +$318,989,000 | +76% | 31 Dec 2020 | 10-K | 15 Feb 2024 | 2023 | FY |
| Q3 2020 | $825,080,000 | +$403,632,000 | +96% | 30 Sep 2020 | 10-Q | 05 Nov 2021 | 2021 | Q3 |
| Q2 2020 | $391,269,000 | +$619,217,000 | 30 Jun 2020 | 10-Q | 05 Nov 2021 | 2021 | Q3 | |
| Q1 2020 | $409,068,000 | +$630,361,000 | 31 Mar 2020 | 10-Q | 05 Nov 2021 | 2021 | Q3 | |
| Q4 2019 | $420,083,000 | +$640,070,000 | 31 Dec 2019 | 10-K | 16 Feb 2023 | 2022 | FY | |
| Q3 2019 | $421,448,000 | +$568,220,000 | 30 Sep 2019 | 10-Q | 12 Nov 2020 | 2020 | Q3 | |
| Q2 2019 | $227,948,000 | -$95,474,000 | -72% | 30 Jun 2019 | 10-Q | 12 Nov 2020 | 2020 | Q3 |
| Q1 2019 | $221,293,000 | -$94,040,000 | -74% | 31 Mar 2019 | 10-Q | 12 Nov 2020 | 2020 | Q3 |
| Q4 2018 | $219,987,000 | -$107,478,000 | -96% | 31 Dec 2018 | 10-K | 18 Feb 2022 | 2021 | FY |
| Q3 2018 | $146,772,000 | 30 Sep 2018 | 10-Q | 12 Nov 2019 | 2019 | Q3 | ||
| Q2 2018 | $132,474,000 | 30 Jun 2018 | 10-Q | 12 Nov 2019 | 2019 | Q3 | ||
| Q1 2018 | $127,253,000 | 31 Mar 2018 | 10-Q | 12 Nov 2019 | 2019 | Q3 | ||
| Q4 2017 | $112,509,000 | -$16,078,000 | -17% | 31 Dec 2017 | 10-K | 26 Feb 2021 | 2020 | FY |
| Q4 2016 | $96,431,000 | 31 Dec 2016 | 10-K | 27 Feb 2020 | 2019 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.